OLMA - CIK 0001750284
The table below shows Olema Pharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $52.55M | $35.26M | $52.47M | $50.64M | $35.89M | $16.89M |
| Short-term investments | $452.80M | $293.70M | $309.44M | $342.07M | $178.88M | $222.21M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $513.23M |
| $334.33M |
| $367.73M |
| $396.66M |
| $217.99M |
| $242.19M |
| Property, plant & equipment | $356.00K | $486.00K | $560.00K | $653.00K | $849.00K | $945.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $530.64M | $352.45M | $382.00M | $409.64M | $230.17M | $254.56M |
| Accounts payable | $3.72M | $3.47M | $934.00K | $151.00K | $2.69M | $4.35M |
| Total current liabilities | $47.17M | $41.66M | $33.16M | $26.06M | $30.70M | $26.54M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $50.17M | $44.97M | $36.77M | $26.19M | $31.26M | $27.39M |
| Retained earnings | -$650.65M | -$551.50M | -$509.28M | -$465.50M | -$401.54M | -$366.98M |
| Total equity | $480.48M | $307.49M | $345.24M | $383.45M | $198.91M | $227.16M |